• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Industry
    • Exhibits and Support & Visibility Opportunities
    • Industry Archives
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2025 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2025 Poster Presentations

2025 Poster Presentations

 

← Back to Previous Page

 

P152: ANALYSIS OF SURVIVAL AND PREDICTION OF RECURRENCE OF ATYPICAL AND ANAPLASTIC MENINGIOMAS BASED ON TUMOR LOCATION
Peter Erickson, BA; Rafael Martinez-Perez; Geisinger Medical Center

Purpose: World Health Organization (WHO) Grade 2 and 3 meningiomas have high rates of recurrence. However, ambiguity remains on the role of radiation therapy as an adjunct to surgery for treatment. In this study, we aim to characterize the longitudinal impact of radiation therapy on progression free survival (PFS) and overall survival (OS) based on several variables including tumor size, location, and type of radiation. In addition we aim to determine wether tumor location (skull base) has significant impact on survival and/or recurrence.

Methods and Materials: Data were collected through retroactive chart reviews for patients with pathologically diagnosed Meningioma who underwent surgical resection with or without radiation therapy between the age of 18 and 100. Progression free survival (PFS) and overall survival (OS) were then calculated. Analysis on tumor location for predictors of PFS was performed. We intend to continue data collection to evaluate response to radiation therapy for tumor size and the type/amount of radiation received. SPSS v 22.0 was used for statistical analysis of Kaplan Meier curves and p < .05 was the threshold for statistical significance.

Results: 25 patients were included in the study from a selected retrospective case series of patients undergoing surgery for meningioma 1,300. 22 (88 %) of the patients had WHO grade II meningiomas and 3 (12%) of the patients had WHO grade III meningiomas. 13 (52%) of the patients were female, while 12 (48%) of the patients were male. Skull based accounted for 4 (16%) of the cranial meningiomas, while 21 (84%) of the meningiomas were convexity. Among the skull based patients, 3 (75%) received radiation therapy in addition to surgical excision. 11 of the convexity based meningioma patients received radiation (52%). No significant differences were found amongst the proportioon of patients with SBM who underwent radiation in comparison to those with Convexity Meningiomas. PFS was significantly shorter for patients with skull base meningiomas compared to convexity (p =0.13, Log rank).

Conclusion: For patients with grade II or III meningiomas, location (skull base) predicts earlier recurrence, while larger series of patients are needed to determine wether this have an impact on survival. Based on these findings, long term follow up with shorter interval MRI is recommended for patients harboring skull base meningiomas.

View Poster

 

← Back to Previous Page

Copyright © 2025 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved